Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SENS

Senseonics (SENS)

Senseonics Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:SENS
FechaHoraFuenteTítuloSímboloCompañía
17/05/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SENSSenseonics Holdings Inc
13/05/202415:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SENSSenseonics Holdings Inc
13/05/202415:13Edgar (US Regulatory)Form 8-K - Current reportAMEX:SENSSenseonics Holdings Inc
13/05/202415:05Business WireSenseonics Holdings, Inc. Reports First Quarter 2024 Financial ResultsAMEX:SENSSenseonics Holdings Inc
13/05/202415:04Business WireSenseonics and Mercy Collaborate to Improve Diabetes Population Health ManagementAMEX:SENSSenseonics Holdings Inc
09/05/202415:05Business WireSenseonics Partners with Rimidi to Develop Innovative Diabetes SolutionAMEX:SENSSenseonics Holdings Inc
02/05/202407:05Business WireSenseonics Holdings, Inc. to Participate in Upcoming ConferencesAMEX:SENSSenseonics Holdings Inc
30/04/202415:05Business WireSenseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern TimeAMEX:SENSSenseonics Holdings Inc
30/04/202406:00Business WireEversense® CGM System Receives iCGM Designation by the US FDAAMEX:SENSSenseonics Holdings Inc
12/03/202406:00PR Newswire (US)SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMSAMEX:SENSSenseonics Holdings Inc
08/03/202407:05Business WireSenseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for DiabetesAMEX:SENSSenseonics Holdings Inc
06/03/202407:05Business WireSenseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services ConferenceAMEX:SENSSenseonics Holdings Inc
29/02/202415:05Business WireSenseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsAMEX:SENSSenseonics Holdings Inc
15/02/202415:05Business WireSenseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern TimeAMEX:SENSSenseonics Holdings Inc
12/02/202406:00PR Newswire (US)MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEMAMEX:SENSSenseonics Holdings Inc
12/02/202406:00Business WireMedicare Coverage Significantly Expanded for the Eversense E3 CGM SystemAMEX:SENSSenseonics Holdings Inc
06/02/202407:00Business WirePHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes CareAMEX:SENSSenseonics Holdings Inc
02/01/202415:05Business WireSenseonics Holdings, Inc. Announces Business UpdatesAMEX:SENSSenseonics Holdings Inc
09/11/202315:05Business WireSenseonics Holdings, Inc. Reports Third Quarter 2023 Financial ResultsAMEX:SENSSenseonics Holdings Inc
09/11/202307:05Business WireSenseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare ConferenceAMEX:SENSSenseonics Holdings Inc
30/10/202315:05Business WireSenseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern TimeAMEX:SENSSenseonics Holdings Inc
09/10/202306:00Business WireAscensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with DiabetesAMEX:SENSSenseonics Holdings Inc
26/09/202307:05Business WireSenseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical StudyAMEX:SENSSenseonics Holdings Inc
14/09/202307:05Business WireSenseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company ShowcaseAMEX:SENSSenseonics Holdings Inc
12/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:SENSSenseonics Holdings Inc
11/09/202316:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:SENSSenseonics Holdings Inc
11/09/202307:05Business WireSenseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules CapitalAMEX:SENSSenseonics Holdings Inc
07/09/202315:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:SENSSenseonics Holdings Inc
10/08/202315:34Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:SENSSenseonics Holdings Inc
10/08/202315:15Business WireSenseonics Holdings, Inc. Reports Second Quarter 2023 Financial ResultsAMEX:SENSSenseonics Holdings Inc
 Showing the most relevant articles for your search:AMEX:SENS